Truist Financial’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,147
Closed -$297K 2823
2025
Q4
$297K Buy
7,147
+2,426
+51% +$98.4K ﹤0.01% 2338
2025
Q3
$218K Buy
+4,721
New +$252K ﹤0.01% 2508
2024
Q1
Sell
-4,484
Closed -$440K 2638
2023
Q4
$440K Buy
+4,484
New +$391K ﹤0.01% 2066
2023
Q2
Sell
-1,686
Closed -$205K 2579
2023
Q1
$205K Buy
+1,686
New +$229K ﹤0.01% 2414
2022
Q2
Sell
-7,754
Closed -$1.29M 2649
2022
Q1
$1.29M Buy
7,754
+6,054
+356% +$1.15M ﹤0.01% 1500
2021
Q4
$303K Buy
1,700
+489
+40% +$87.3K ﹤0.01% 2350
2021
Q3
$214K Buy
+1,211
New +$201K ﹤0.01% 2528

Other funds holding CNXC

Truist Financial's CNXC Position: Q1 2026 in Review

Truist Financial sold out of Concentrix (CNXC) in Q1 2026, closing a stake of 7,147 shares — an estimated $297K sold.

Truist Financial first reported a position in CNXC in Q3 2021 and held it in 7 quarters. The position peaked at $1.29M in Q1 2022. 302 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • Truist Financial reported no remaining Concentrix position as of Q1 2026 after selling out during the quarter.
  • Truist Financial sold 7,147 Concentrix shares in Q1 2026, an estimated $297K.
  • Truist Financial first reported a position in Concentrix in Q3 2021 and held it in 7 quarters.
  • Truist Financial's Concentrix position peaked at $1.29M in Q1 2022.
  • 302 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.